推薦產品
等級
SAJ first grade
蒸汽密度
4.63 (vs air)
蒸汽壓力
0.12 mmHg ( 20 °C)
化驗
≥98.0%
形狀
liquid
expl. lim.
1.2 %, 135 °F
23.5 %, 182 °F
存貨情形
available only in Japan
折射率
n20/D 1.427 (lit.)
bp
202 °C (lit.)
密度
0.999 g/mL at 25 °C (lit.)
SMILES 字串
CCOCCOCCO
InChI
1S/C6H14O3/c1-2-8-5-6-9-4-3-7/h7H,2-6H2,1H3
InChI 密鑰
XXJWXESWEXIICW-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
法律資訊
CARBITOL is a trademark of The Dow Chemical Company or an affiliated company of Dow
儲存類別代碼
10 - Combustible liquids
水污染物質分類（WGK）
WGK 1
閃點（°F）
204.8 °F - closed cup
閃點（°C）
96 °C - closed cup
個人防護裝備
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
Yousef Javadzadeh et al.
Colloids and surfaces. B, Biointerfaces, 82(2), 422-426 (2010-10-19)
Regarding the potential severe toxicity associated with systemic administration of methotrexate (MTX), a topical formulation might be of greater utility for the treatment of psoriasis and other hyperproliferative skin disorders. One of the presumed reasons for the lack of clinical
Liandong Hu et al.
International journal of pharmaceutics, 420(2), 251-255 (2011-09-13)
The objective of the present study was to formulate a microemulsion system for oral administration to improve the solubility and bioavailability of fenofibrate. Various formulations were prepared using different ratios of oils, surfactants and co-surfactants (S&CoS). Pseudo-ternary phase diagrams were
Dong Hoon Oh et al.
International journal of pharmaceutics, 420(2), 412-418 (2011-09-29)
In order to compare the effects of hydrophilic and hydrophobic solid carrier on the formation of solid self-microemulsifying drug delivery system (SMEDDS), two solid SMEDDS formulations were prepared by spray-drying the solutions containing liquid SMEDDS and solid carriers. Colloidal silica
Hyun-Jong Cho et al.
International journal of pharmaceutics, 423(2), 153-160 (2012-01-03)
To achieve rapid onset of action and improved bioavailability of udenafil, a microemulsion system was developed for its intranasal delivery. Phase behavior, particle size, transmission electron microscope (TEM) images, and the drug solubilization capacity of the microemulsion were investigated. A
Roberta Censi et al.
Drug development and industrial pharmacy, 38(9), 1128-1133 (2011-12-23)
A microemulsion for the cutaneous release of quercetin was prepared. An aqueous phase, containing 40% Transcutol® P as solubilizing agent and permeation enhancer, was emulsified with Labrafil® as oil phase and Labrasol®/Capryol™ 90 as Solvent/Co-solvent. Quercetin was dissolved in the
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務